Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • montenegro
    Junior Member
    • Feb 2016
    • 1

    Ribosomal depletion for RNA seq

    We are currently embarking on an RNAseq project using a sequencing service provider but have a few questions concerning the ribosomal RNA depletion step (Ribo Zero) that would markedly add to the cost of the project.

    Our initial quotation (TruSeq RNA kit) without depletion is quite competitive. Is it necessary to carry out the depletion step if the RNA is to be further fractionated via a polyA step? Does anyone have an idea how much ribosomal RNA would carry over past the polyA isolation? Could this ribosomal RNA be depleted via bioinformatics?

    We realize that its presence would reduce the proportion of sequences of interest but are unsure as to how much it would do so relative to the added cost. We would appreciate anyone’s thoughts on this and thank-you in advance.
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    For reference cross-posted: https://www.biostars.org/p/176059/

    Comment

    • nucacidhunter
      Jafar Jabbari
      • Jan 2013
      • 1250

      #3
      More than 90% of total RNA is rRNA, so without further fractionation you will be sequencing mostly rRNA. Two options:

      1- mRNA-Seq on polyA selected RNA that does not require depletion. This option also requires less sequencing.

      2- Total RNA-Seq that requires Ribo-Zero or other rRNA depletion reagent and library includes both polyA and non-polyA RNA (total RNA without rRNA). This option cost more because of depletion reagents and also more sequencing requirement.

      In both method up to 3% of reads can be from rRNA.

      Comment

      • blancha
        Senior Member
        • May 2013
        • 367

        #4
        I don't understand your post.
        You either do ribo-depletion or poly-A enrichment, not both.
        You have to pick one or the other, or you will be sequencing mainly rRNA, which is not very useful.

        Comment

        • LOH
          Registered Vendor
          • Jul 2010
          • 23

          #5
          You choose either rRNA depletion (using RNase H) or poly-A enrichment (using poly-A beads) or rRNA exclusion (using specific primers).

          We are professional at all three RNA Sequencing Service.
          Last edited by LOH; 03-24-2016, 06:57 PM.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            Today, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 11:10 AM
          0 responses
          7 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          29 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Working...